Multiple sclerosis and COVID‐19: How many are at risk?

BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID‐19) pandemic challenges neurologists in counseling multiple sclerosis (MS) patients with respect to their risk for and by severe acute respiratory syndrome coronavirus 2 and in guiding disease‐modifying treatment (DMT). The objective was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Bitschnau, Christina, Hegen, Harald, Auer, Michael, Di Pauli, Franziska, Rommer, Paulus, Deisenhammer, Florian, Berger, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537184/
https://www.ncbi.nlm.nih.gov/pubmed/32978860
http://dx.doi.org/10.1111/ene.14555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537184/
https://www.ncbi.nlm.nih.gov/pubmed/32978860
http://dx.doi.org/10.1111/ene.14555

Ejemplares similares